ST Pharm financials at a glance

+ Portfolio

The revenue of ST Pharm is reported as 284.104 billion Won in the fiscal year 2023. The earnings were 1041 Won per share in 2023, which was 3.89 higher than 2022. And about 9.24466 billion Won are reported as free cash flow in the financials of ST Pharm 2023. Dividends of 500 Won per share were paid to shareholders of ST Pharm stock KOSDAQ:A237690 in fiscal 2023.

₩284.10B

Revenue

₩1.04k

Earnings Per Share

38.51%

Gross Margin %

₩1.43B

Free Cash Flow

Revenue

284,104.00

Earnings Per Share

1,041.00

Gross Margin %

38.51

Free Cash Flow

1,433.33

Financials

Year	Year	TTM	2023	2022	2021	2020	2018	2017	2016
Rev.	Revenue	N/A	₩284.10B	₩249.32B	₩165.64B	₩124.16B	₩97.74B	₩202.80B	₩200.36B
GM %	Gross Margin %	37.99%	38.51%	34.97%	33.39%	14.78%	2.61%	39.26%	46.32%
OM	Operating Margin	8.02%	11.76%	7.16%	3.37%	-15.16%	-16.01%	30.49%	38.72%
EPS	Earnings Per Share	₩614.01	₩1.04k	₩1.00k	₩177.00	₩-,651.00	₩-,497.00	₩2.41k	₩3.76k
Div.	Dividends	N/A	₩500.00	₩500.00	₩0.00	₩0.00	₩500.00	₩500.00	₩500.00
PR %	Payout Ratio %	0	48.03%	49.90%	0	-0.00%	-,100.60%	20.74%	13.30%
Sha.	Shares	N/AM	18.81M	18.81M	18.81M	18.66M	18.66M	18.66M	18.48M
OCF	Operating Cash Flow	N/A	₩52.49B	₩7.03B	₩7.27B	₩-20,934.77M	₩54.10B	₩54.44B	₩50.78B
FCF	Free Cash Flow	N/A	₩1.43B	₩-53,447.68M	₩-44,522.45M	₩-37,924.01M	₩28.90B	₩26.74B	₩34.75B
FCFS	Free Cash Flow Per Share	₩-2,463.00	₩-2,240.54	₩-2,835.87	₩-2,392.66	₩-2,057.21	₩-,886.85	₩1.44k	₩2.18k

ST Pharm financials at a glance

Financials

Discover